Bo Yu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Endocrinology top 5%
Papers in
-
- MicroRNA in disease regulation 9
-
- RNA Interference and Gene Delivery 11
- Cancer-related gene regulation 3
- Circular RNAs in diseases 3
- Co-authors
- Zhijun Min (8 shared papers)Yang Zhou (8 shared papers)Dejun Wu (4 shared papers)Tingfeng Wang (3 shared papers)Robert J. Lee (12 shared papers)James L. Lee (1 shared paper)Kitty Agarwal (1 shared paper)Ruju Chen (1 shared paper)
- Journals
- Blood (7 papers)Molecular Pharmaceutics (4 papers)The Lancet Public Health (2 papers)Journal of Clinical Investigation (2 papers)The Lancet Global Health (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bo Yu
104 papers receiving 3.7k citations
Bo Yu's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 284
- Endocrinology 82
- Molecular Biology 1.2k
- Biomaterials 197
- Pathology and Forensic Medicine 268
Countries citing papers authored by Bo Yu
This map shows the geographic impact of Bo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Yu more than expected).
Fields of papers citing papers by Bo Yu
This network shows the impact of papers produced by Bo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Yu. The network helps show where Bo Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China Hit paper breakdown → | 2019 | 387 |
| 2 | 2013 | 239 | |
| 3 | 2020 | 216 | |
| 4 | 2014 | 149 | |
| 5 | The role of m6A methylation in therapy resistance in cancer Hit paper breakdown → | 2023 | 145 |
| 6 | 2018 | 138 | |
| 7 | 2015 | 134 | |
| 8 | 2022 | 125 | |
| 9 | 2009 | 107 | |
| 10 | 2008 | 91 | |
| 11 | 2014 | 90 | |
| 12 | 2021 | 88 | |
| 13 | 2005 | 85 | |
| 14 | 2003 | 82 | |
| 15 | 2017 | 81 | |
| 16 | 2014 | 80 | |
| 17 | 2018 | 78 | |
| 18 | 2021 | 78 | |
| 19 | Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. | 2009 | 71 |
| 20 | 2018 | 71 |
About Bo Yu
Bo Yu is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Immunology, having authored 108 papers that have together received 3.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (11 papers), MicroRNA in disease regulation (9 papers), Cerebrovascular and Carotid Artery Diseases (8 papers), Chronic Lymphocytic Leukemia Research (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Bariatric Surgery and Outcomes (3 papers), Cancer-related gene regulation (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (284 citations), Endocrinology (82 citations), Molecular Biology (1.2k citations), Biomaterials (197 citations) and Pathology and Forensic Medicine (268 citations). Bo Yu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhijun Min, Yang Zhou, Dejun Wu, Tingfeng Wang, Robert J. Lee, James L. Lee, Kitty Agarwal, Ruju Chen, Zhi Zhang and Jinyun Tan. Their work appears in journals such as Blood, Molecular Pharmaceutics, The Lancet Public Health, Journal of Clinical Investigation and The Lancet Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.